Bristol-Myers Squibb Company 345 Park Avenue New York, New York 10154
EX-10.B 3 bmyex10bextensionnoticefor.htm EXHIBIT 10.B BMY Ex 10b Extension Notice for 2012 Credit Agreement
EXHIBIT 10b.
Bristol-Myers Squibb Company
345 Park Avenue
New York, New York 10154
Citibank, N.A., as Administrative Agent
388 Greenwich Street
New York, New York 10013
Attention: Richard Rivera
June 1, 2015
Ladies and Gentlemen:
Re: Extension of Maturity Date
Reference is made to the Five Year Competitive Advance and Revolving Credit Facility Agreement (the “Credit Agreement”) dated as of July 30, 2012 among Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), the Borrowing Subsidiaries, the lenders parties thereto (the “Lenders”), certain Agents, Citibank, N.A., as Administrative Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent. Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.
Pursuant to Section 2.5 of the Credit Agreement, the Company hereby requests that the Lenders extend the Maturity Date in effect on the date hereof (i.e., July 30, 2019) to the first anniversary of such Maturity Date, such that the extended Maturity Date under the Credit Agreement will be July 30, 2020. This letter shall constitute an “Extension Letter” as referred to in Section 2.5 of the Credit Agreement.
Very truly yours, BRISTOL-MYERS SQUIBB COMPANY |
By: /s/ Jeffrey Galik Name: Jeffrey Galik Title: Senior Vice President and Treasurer |
E-10-2